Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -14.22 is 92% above its 5-year average of -169.23, near the high end of its 5-year range (-245.80–-11.60).
80.94% above its 12-month average of -74.60.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -4.02.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:31:04.333Z. Historical observations retain their original dates. Historical series through 2013-03-13.
EARNINGS PER SHARE (EPS)
-14.22
EARNINGS PER SHARE (EPS) AVG TTM
-74.60
EARNINGS PER SHARE (EPS) AVG 3Y
-142.80
EARNINGS PER SHARE (EPS) AVG 5Y
-169.23
EARNINGS PER SHARE (EPS) AVG 10Y
-657.40
EARNINGS PER SHARE (EPS) AVG 15Y
-256.63
EARNINGS PER SHARE (EPS) AVG 20Y
-292.01
CURRENT VS TTM AVG
+80.94%
CURRENT VS 3Y AVG
+90.04%
CURRENT VS 5Y AVG
+91.60%
CURRENT VS 10Y AVG
+97.84%
CURRENT VS 15Y AVG
+94.46%
CURRENT VS 20Y AVG
+95.13%
Curis, Inc.
Market Cap
$1.46M
Earnings Per Share (EPS)
-14.22
TTM Avg
-74.60
3Y Avg
-142.80
5Y Avg
-169.23
Market Cap
$1.47M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.44
3Y Avg
-0.57
5Y Avg
-0.58
Market Cap
$1.49M
Earnings Per Share (EPS)
-1815.30
TTM Avg
-34855.30
3Y Avg
-136953.83
5Y Avg
-91453.81
Market Cap
$1.42M
Earnings Per Share (EPS)
-30.76
TTM Avg
-1622.27
3Y Avg
-9301.43
5Y Avg
-16503.78
Market Cap
$1.52M
Earnings Per Share (EPS)
-10.02
TTM Avg
-4.85
3Y Avg
-7.18
5Y Avg
-7.18
Market Cap
$1.39M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
Market Cap
$1.34M
Earnings Per Share (EPS)
-74.28
TTM Avg
-29.19
3Y Avg
-19.57
5Y Avg
-19.24
Market Cap
$1.33M
Earnings Per Share (EPS)
N/A
TTM Avg
-14.23
3Y Avg
-10.02
5Y Avg
-9.01
Market Cap
$1.32M
Earnings Per Share (EPS)
-158.78
TTM Avg
-3127.89
3Y Avg
-13218.44
5Y Avg
-15729.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curis, Inc. (CRIS) | $1.46M | -14.22 | -74.60 | -142.80 | -169.23 |
| NEXGEL, Inc. (NXGL)vs › | $1.47M | -0.71 | -0.44 | -0.57 | -0.58 |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -1815.30 | -34855.30 | -136953.83 | -91453.81 |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -30.76 | -1622.27 | -9301.43 | -16503.78 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | -10.02 | -4.85 | -7.18 | -7.18 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.39M | -19.33 | -12.55 | -11.71 | -15.69 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | -74.28 | -29.19 | -19.57 | -19.24 |
| NewcelX Ltd. (NCEL)vs › | $1.33M | N/A | -14.23 | -10.02 | -9.01 |
| Genprex, Inc. (GNPX)vs › | $1.32M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -5.35 | -12.67 | -17.25 | -14.07 |
Trailing EPS (TTM)
$-14.22
Forward EPS (Est.)
$-47.14
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -11.60 |
| 2024-12-31 | -137.60 |
| 2023-12-31 | -179.20 |
| 2022-12-31 | -242.80 |
| 2021-12-31 | -198.40 |
| 2020-12-31 | -245.80 |
| 2019-12-31 | -387.40 |
| 2018-12-31 | -393.40 |
| 2017-12-31 | -3575.20 |
| 2016-12-31 | -900.00 |
| 2015-12-31 | -960.00 |
| 2014-12-31 | -440.00 |
| 2013-12-31 | -300.00 |
| 2012-12-31 | -420.00 |
| 2011-12-31 | -260.00 |
| 2010-12-31 | -120.00 |
| 2009-12-31 | -300.00 |
| 2008-12-31 | -380.00 |
| 2007-12-31 | -260.00 |
| 2006-12-31 | -360.00 |
| 2005-12-31 | -620.00 |
| 2004-12-31 | -660.00 |
| 2003-12-31 | -33.00 |
| 2001-12-31 | -5139.20 |
| 2000-12-31 | -39601.20 |
| 1999-12-31 | -2267.40 |
